Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 881 of 5804
-
Smart insulin pumps may replace IV drips during childbirth for diabetic moms
Disease control Recruiting nowThe goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcome…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New obesity drug HM15275 enters Mid-Stage trial
Disease control OngoingThis Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New MRI technique aims to help surgeons remove more of a deadly brain tumor
Disease control TerminatedMagnetic resonance imaging, MRI, is a procedure that uses radio waves, a powerful magnet, and a computer to make a series of detailed pictures of areas inside the body. The goal of this study is to determine if MR fingerprinting, new way of acquiring MRI images, can help identify…
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Blood test could replace needle biopsies for breast cancer staging
Diagnosis Not yet recruitingThrough the research of this project, we expect to achieve the cfDNA fragment omics liquid biopsy technology based on deep learning, verify the accuracy of the TuFEst model in predicting the tumor burden status of breast cancer lesions and lymph nodes in newly diagnosed breast ca…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Real-World data may reveal how well tafasitamab fights Hard-to-Treat lymphoma
Disease control OngoingTo evaluate the efficacy of tafasitamab in patients with relapsed/ refractory diffuse large B-cell lymphoma \*To evaluate best objective response rate (ORR)
Sponsor: TTY Biopharm • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a blood protein boost survival in septic shock?
Disease control Not yet recruitingThis study will test whether giving human albumin to keep the blood albumin level above 3.5 g/dL, in addition to standard care, improves survival in patients with surgical septic shock. Septic shock is a life-threatening complication of infection that often requires urgent surger…
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental cell therapy targets autoimmune diseases that Won't quit
Disease control Recruiting nowThis study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and SLE-ITP, Sjogren's Syndrome, etc. Aproximately 18 patients aged 18-65 will receive a single infusion o…
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New antibody therapy targets stubborn autoimmune blood diseases
Disease control Recruiting nowTo evaluate the efficacy and safety of CM336 (BCMA/CD3 Bispecific Antibody) in the treatment of patients with relapsed or refractory autoimmune cytopenia
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Survivor stories aim to boost HPV shots in kids
⭐️ VACCINE ⭐️ Recruiting nowThis randomized controlled trial (RCT) evaluates the association of a narrative communication intervention on human papillomavirus (HPV) vaccination rates among 9- to 12-year-olds. The intervention is a brief video from local cancer survivors narrating their stories with an HPV-r…
Phase: NA • Sponsor: Milton S. Hershey Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
Experimental CAR-T therapy takes on tough leukemia
Disease control Not yet recruitingA Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia.
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New lens implants promise clearer vision for complex cataract cases
Disease control Recruiting nowThe goal of cataract surgery has evolved from simply restoring sight to providing clear and comfortable full-range vision. Traditionally, monofocal IOLs remain the routine choice for special cases with anterior segment abnormalities-such as lens subluxation, cataract with chronic…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New Single-Dose flu drug for kids shows promise in trial
Symptom relief Recruiting nowThe goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.
Phase: PHASE3 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New oral drug aims to restore skin color in vitiligo
Disease control Recruiting nowTo evaluate the efficacy of QY201 Tablets in adult subjects with non-segmental vitiligo, and to provide evidence for dose selection in the confirmatory Phase III clinical trial.
Phase: PHASE2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a daily ultrasound zap arthritis pain at home?
Disease control Recruiting nowThe At-Home ULTRA Study will evaluate performance of the MINI system as indicated for the treatment of adults with active, moderate to severe rheumatoid arthritis who are inadequate responders or are intolerant to conventional synthetic disease-modifying anti-rheumatic drugs (csD…
Phase: NA • Sponsor: SecondWave Systems Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Zapping heart trouble: radiation may replace needle procedure for dangerous rhythms
Disease control Recruiting nowThe goal of this randomized clinical trial is to test the efficacy of stereotactic body radiation therapy (SBRT) in treating ventricular tachycardia (VT) in patients with advanced structural heart disease. The main questions it aims to answer are: * What is the efficacy of SBRT …
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Laser and steroid mouthwash aim to tame painful mouth sores in autoimmune disease
Disease control Recruiting nowPemphigus vulgaris (PV) is a chronic, potentially life-threatening autoimmune mucocutaneous disorder that significantly impairs patients' quality of life. While systemic corticosteroids and immunosuppressants remain the standard of care, many patients suffer from persistent, pain…
Phase: NA • Sponsor: Damascus University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill aims to recolor white patches in vitiligo patients
Disease control Recruiting nowThis clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New gel could boost fertility for couples struggling to conceive
Disease control Recruiting nowThe test medication Gel PKB171 is a vaginal gel that has not yet been licensed by the regulatory authorities. However, the active substance pentoxifylline has been available as tablets for decades and is used to increase peripheral blood flow in patients with circulation problems…
Phase: PHASE2, PHASE3 • Sponsor: Prokrea BCN, S.L. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could drug holidays ease fatigue in prostate cancer? new trial investigates
Disease control Recruiting nowThe purpose of this study is to evaluate intermittent relugolix + androgen receptor pathway inhibitor (ARPI) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) achieving optimal PSA response.
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New yellow fever vaccine shows promise in japanese adults
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to assess the safety and immunogenicity of vYF in adults aged 18 years and over in Japan. Study details include: * The study duration will be up to approximately 1 month. * One single dose of vYF will be administrated subcutaneously at the 1st visit…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:01 UTC